Debt-to-equity of Protalix BioTherapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Protalix BioTherapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Protalix BioTherapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 61%, a 63% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 61% -102% -63% 30 Sep 2025
Q2 2025 68% -103% -60% 30 Jun 2025
Q1 2025 101% -48% -32% 31 Mar 2025
Q4 2024 136% -56% -29% 31 Dec 2024
Q3 2024 163% -178% -52% 30 Sep 2024
Q2 2024 171% -1227% -88% 30 Jun 2024
Q1 2024 149% +1021% 31 Mar 2024
Q4 2023 192% +903% 31 Dec 2023
Q3 2023 341% +1184% 30 Sep 2023
Q2 2023 1398% +2732% 30 Jun 2023
Q1 2023 -872% +2753% +76% 31 Mar 2023
Q4 2022 -711% -3551% -125% 31 Dec 2022
Q3 2022 -843% +3531% +81% 30 Sep 2022
Q2 2022 -1334% -397% -42% 30 Jun 2022
Q1 2022 -3625% -3135% -639% 31 Mar 2022
Q4 2021 2840% +3174% 31 Dec 2021
Q3 2021 -4374% -4113% -1577% 30 Sep 2021
Q2 2021 -936% -713% -320% 30 Jun 2021
Q1 2021 -490% -291% -146% 31 Mar 2021
Q4 2020 -334% -154% -85% 31 Dec 2020
Q3 2020 -261% -69% -36% 30 Sep 2020
Q2 2020 -223% -16% -7.8% 30 Jun 2020
Q1 2020 -199% +19% +8.6% 31 Mar 2020
Q4 2019 -180% +56% +24% 31 Dec 2019
Q3 2019 -192% +72% +27% 30 Sep 2019
Q2 2019 -207% +80% +28% 30 Jun 2019
Q1 2019 -218% +112% +34% 31 Mar 2019
Q4 2018 -236% +47% +16% 31 Dec 2018
Q3 2018 -264% +55% +17% 30 Sep 2018
Q2 2018 -287% +62% +18% 30 Jun 2018
Q1 2018 -330% +69% +17% 31 Mar 2018
Q4 2017 -283% +867% +75% 31 Dec 2017
Q3 2017 -319% +3275% +91% 30 Sep 2017
Q2 2017 -348% +265% +43% 30 Jun 2017
Q1 2017 -399% -41% -11% 31 Mar 2017
Q4 2016 -1149% -889% -342% 31 Dec 2016
Q3 2016 -3594% -3384% -1610% 30 Sep 2016
Q2 2016 -613% -382% -165% 30 Jun 2016
Q1 2016 -358% -96% -36% 31 Mar 2016
Q4 2015 -260% +45% +15% 31 Dec 2015
Q3 2015 -210% +159% +43% 30 Sep 2015
Q2 2015 -231% +240% +51% 30 Jun 2015
Q1 2015 -262% +286% +52% 31 Mar 2015
Q4 2014 -306% +387% +56% 31 Dec 2014
Q3 2014 -369% +597% +62% 30 Sep 2014
Q2 2014 -471% +1340% +74% 30 Jun 2014
Q1 2014 -549% -10811% -105% 31 Mar 2014
Q4 2013 -692% -11541% -106% 31 Dec 2013
Q3 2013 -966% +550% +36% 30 Sep 2013
Q2 2013 -1811% -1079% -148% 30 Jun 2013
Q1 2013 10262% +10794% 31 Mar 2013
Q4 2012 10849% 31 Dec 2012
Q3 2012 -1517% 30 Sep 2012
Q2 2012 -732% 30 Jun 2012
Q1 2012 -532% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.